Axcelis Technologies
ACLS · NASDAQ
About ACLS
- Employees
- 1,465
- Headquarters
- Beverly, Massachusetts
- Listed
- Jul 11, 2000
- Sector
- Information Technology
- Industry
- Semiconductors & Semiconductor Equipment
- Website
- axcelis.com
ACLS key statistics
- Market cap
- 3.43B
- Price-earnings ratio
- 37.32
- Dividend yield
- —
- Average volume
- 325.88K
- Volume
- 153.61K
- Open price
- $110.61
- High today
- $113.82
- Low today
- $106.80
- 52 Week high
- $193.78
- 52 Week low
- $73.60
Axcelis Technologies (ACLS) at a glance
Axcelis Technologies (ACLS) last traded at $112.93, with a market cap of 3.43B and a price-to-earnings ratio of 37.32.
Today the stock has traded between $106.80 and $113.82. The current price is 5.7% above the day's low and 0.8% below its high.
Volume so far is 153.61K shares, below the average of 325.88K shares a day.
Over the past year Axcelis Technologies has ranged from $73.60 to $193.78, and now sits 33% of the way up that range.
Axcelis Technologies met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $1.06 per share against an estimate of $0.9115.
The average analyst price target is $160.03, 41.7% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold50.0%
- Sell50.0%
- Low
- $141.40
- Now
- $112.93
- High
- $207.90
ACLS earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 43.4% on average.
- Q3 FY24: reported $1.49 per share against an estimate of $1.46
- Q4 FY24: reported $1.54 per share against an estimate of $1.27
- Q1 FY25: reported $1.04 per share against an estimate of $0.394
- Q2 FY25: reported $1.13 per share against an estimate of $0.7446
- Q3 FY25: reported $1.21 per share against an estimate of $1.02
- Q4 FY25: reported $1.49 per share against an estimate of $1.14
- Q1 FY26: reported $0.72 per share against an estimate of $0.7245
- Q2 FY26: reported $1.06 per share against an estimate of $0.9115
ACLS news
- Press releasePRNewswire
- Press releasePRNewswire
Axcelis Announces Sponsorship and Participation in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026)
- Press releasePRNewswire
Axcelis Announces Sponsorship and Participation in the 25th International Conference on Ion Implantation and Annealing Technology 2026
- Press releasePRNewswire
Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea
- Radhika Anilkumar Nadig
South Korea Lands $2 Billion From 4 US Companies as Trump Turns Up Pressure on Foreign Chipmakers: GLW, APD, ACLS Among Stocks in Focus
- Press releasePRNewswire
Axcelis Announces Participation in Upcoming Investor Conferences
- Press releasePRNewswire
Axcelis Announces Financial Results for Second Quarter 2026
- Press releasePRNewswire
Axcelis Announces Participation in Upcoming Investor Conferences in August
Similar companies
Companies in the same industry as Axcelis Technologies
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.